We're jumping right into another busy day of trading with a breakdown of the biggest pre-market stock movers for Tuesday! More
Articles
Atossa Therapeutics Stock Lost Its Covid Mojo, and Its Pipeline Fails To Impress
Atossa’s COVID-19 treatment is too little too late and I am concerned about the market size for Endoxiden. ATOS stock should not have a $448 million market cap. More
Even as It Struggles, Skillz Stock Is Worth Loading up on Here
Skillz lost 28% in the past month. Investors are skeptical about the video-game platform ever making money. Does that make SKLZ stock a sell? More
Robinhood Stock Is Going to Take a While to Come Into Its Own
Although Robinhood has strong, longer-term opportunities, the company is facing powerful medium-term challenges. Investors should avoid HOOD stock. More
Beijing’s ‘Communists’ Have Tech Stocks Like Baidu Down… but for How Long?
China would like to have an antitrust policy and spread its tech wealth, but the example of Baidu proves that's trickier than it thought. BIDU stock may be down, but not for long. More
‘Lifestyle’ EV-Maker Canoo Stock’s Problems Won’t Get Fixed by Politics
While GOEV stock might superficially benefit from the regulatory environment, its problems are too extensive to be solved easily by Canoo. More
Context Logic Had a Disastrous Q2, and Q3 Could Be Even Worse
The cracks in Wish Stock 's business model have become apparent with its recent dismal second quarter results More
